SI1928872T1 - Novi sulfonilpiroli kot inhibitorji HDAC - Google Patents
Novi sulfonilpiroli kot inhibitorji HDACInfo
- Publication number
- SI1928872T1 SI1928872T1 SI200631335T SI200631335T SI1928872T1 SI 1928872 T1 SI1928872 T1 SI 1928872T1 SI 200631335 T SI200631335 T SI 200631335T SI 200631335 T SI200631335 T SI 200631335T SI 1928872 T1 SI1928872 T1 SI 1928872T1
- Authority
- SI
- Slovenia
- Prior art keywords
- hdac
- inhibitors
- sulphonylpyrroles
- novel
- novel sulphonylpyrroles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05108728 | 2005-09-21 | ||
| EP06793379A EP1928872B1 (en) | 2005-09-21 | 2006-09-08 | Novel sulphonylpyrroles as inhibitors of hdac |
| PCT/EP2006/066197 WO2007039404A1 (en) | 2005-09-21 | 2006-09-08 | Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1928872T1 true SI1928872T1 (sl) | 2012-06-29 |
Family
ID=37035343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200631335T SI1928872T1 (sl) | 2005-09-21 | 2006-09-08 | Novi sulfonilpiroli kot inhibitorji HDAC |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8232297B2 (sl) |
| EP (1) | EP1928872B1 (sl) |
| JP (1) | JP5305910B2 (sl) |
| KR (1) | KR101256846B1 (sl) |
| CN (1) | CN101268070B (sl) |
| AR (1) | AR057824A1 (sl) |
| AT (1) | ATE549333T1 (sl) |
| AU (1) | AU2006298882B2 (sl) |
| BR (1) | BRPI0617167B8 (sl) |
| CA (1) | CA2622673C (sl) |
| CY (1) | CY1112780T1 (sl) |
| DK (1) | DK1928872T3 (sl) |
| EA (1) | EA016345B1 (sl) |
| ES (1) | ES2381962T3 (sl) |
| HK (1) | HK1124320A1 (sl) |
| HR (1) | HRP20120399T1 (sl) |
| IL (1) | IL189782A (sl) |
| NO (1) | NO341744B1 (sl) |
| NZ (1) | NZ566074A (sl) |
| PL (1) | PL1928872T3 (sl) |
| PT (1) | PT1928872E (sl) |
| RS (1) | RS52383B (sl) |
| SI (1) | SI1928872T1 (sl) |
| TW (1) | TWI406846B (sl) |
| WO (1) | WO2007039404A1 (sl) |
| ZA (1) | ZA200801394B (sl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| CA2359244C (en) | 1999-01-13 | 2013-10-08 | Bayer Corporation | .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| DK1478358T3 (da) | 2002-02-11 | 2013-10-07 | Bayer Healthcare Llc | Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese |
| PT1626714E (pt) | 2003-05-20 | 2007-08-24 | Bayer Pharmaceuticals Corp | Diarilureias para doenças mediadas por pdgfr |
| ES2297490T3 (es) | 2003-07-23 | 2008-05-01 | Bayer Pharmaceuticals Corporation | Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones. |
| EP1725528B1 (en) | 2004-03-11 | 2013-05-29 | 4Sc Ag | Sulphonylpyrroles as hdac inhibitors |
| NZ560267A (en) | 2005-03-15 | 2010-03-26 | 4Sc Ag | N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| US8188138B2 (en) * | 2005-09-21 | 2012-05-29 | 4Sc Ag | Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
| US8232297B2 (en) | 2005-09-21 | 2012-07-31 | 4Sc Ag | Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles |
| EP2100878A1 (en) | 2008-03-12 | 2009-09-16 | 4Sc Ag | Novel method for the production of sulphonylpyrroles as HDAC inhibitors |
| EP2100882A1 (en) * | 2008-03-12 | 2009-09-16 | 4Sc Ag | (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts |
| EP2330894B8 (en) | 2008-09-03 | 2017-04-19 | BioMarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors |
| DK2680694T3 (en) | 2011-02-28 | 2019-03-25 | Biomarin Pharm Inc | HISTONDEACETYLASE INHIBITORS |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| EP2760471B9 (en) * | 2011-09-30 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Therapeutic peptides |
| AU2012362726A1 (en) * | 2011-12-29 | 2014-07-24 | Pharmacyclics Llc | Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8 |
| US9464089B2 (en) | 2012-01-13 | 2016-10-11 | Acea Biosciences Inc. | Heterocyclic compounds and uses thereof |
| CA2861010A1 (en) | 2012-01-13 | 2013-07-18 | Xiao Xu | Heterocyclic compounds and uses as anticancer agents |
| US9034885B2 (en) | 2012-01-13 | 2015-05-19 | Acea Biosciences Inc. | EGFR modulators and uses thereof |
| WO2014025486A1 (en) * | 2012-08-06 | 2014-02-13 | Acea Biosciences Inc. | Novel pyrrolopyrimidine compounds as inhibitors of protein kinases |
| AU2014228344C1 (en) | 2013-03-15 | 2019-02-07 | Biomarin Pharmaceutical Inc. | HDAC inhibitors |
| CA2917364C (en) | 2013-07-11 | 2020-09-29 | Acea Biosciences Inc. | Heterocyclic compounds and uses thereof |
| CA3001744A1 (en) | 2015-10-09 | 2017-04-13 | ACEA Therapeutics, Inc. | Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same |
| CN105622680B (zh) * | 2015-12-22 | 2018-01-19 | 杭州卢普生物科技有限公司 | 一种舒尼替尼衍生物及其制备方法和应用 |
| JP2019511544A (ja) | 2016-04-14 | 2019-04-25 | ４エスツェー アクチェンゲゼルシャフト | アジア人患者におけるレスミノスタットの医薬用途 |
| JP2020516682A (ja) | 2017-04-07 | 2020-06-11 | エイシア セラピューティクス， インコーポレイテッド | ピロロピリミジンキナーゼの薬学的な塩、物理的形態および組成物、ならびにその作製方法 |
| TW201912183A (zh) | 2017-08-31 | 2019-04-01 | 德商４Ｓｃ製藥公司 | Hdac抑制劑與抗代謝藥劑組合用於癌症治療 |
| CN110496136A (zh) * | 2018-05-17 | 2019-11-26 | 王孝恩 | 锂制剂在制备治疗或预防癌症药物中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960787A (en) | 1989-02-06 | 1990-10-02 | Ciba-Geigy Corporation | Certain pyrrolyl-substituted hydroxamic acid derivatives |
| DK0570594T3 (sl) | 1991-12-10 | 1997-08-25 | Shionogi & Co | |
| WO1996038418A1 (en) | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| EP1259506A1 (en) | 1999-11-23 | 2002-11-27 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| US6541661B1 (en) | 1999-11-23 | 2003-04-01 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| JP4529119B2 (ja) | 2001-08-09 | 2010-08-25 | 小野薬品工業株式会社 | カルボン酸誘導体化合物およびその化合物を有効成分として含有する薬剤 |
| US7868204B2 (en) | 2001-09-14 | 2011-01-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
| AU2002327627B2 (en) | 2001-09-14 | 2006-09-14 | Methylgene Inc. | Inhibitors of histone deacetylase |
| US7482488B2 (en) | 2002-08-29 | 2009-01-27 | Temple University - Of The Commonwealth System Of Higher Education | Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof |
| GB0226855D0 (en) | 2002-11-18 | 2002-12-24 | Queen Mary & Westfield College | Histone deacetylase inhibitors |
| WO2005020921A2 (en) | 2003-08-29 | 2005-03-10 | Exelixis, Inc. | C-kit modulators and methods of use |
| CA2553513A1 (en) | 2004-01-22 | 2005-08-04 | Altana Pharma Ag | N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors |
| US20050197336A1 (en) | 2004-03-08 | 2005-09-08 | Miikana Therapeutics Corporation | Inhibitors of histone deacetylase |
| EP1725528B1 (en) | 2004-03-11 | 2013-05-29 | 4Sc Ag | Sulphonylpyrroles as hdac inhibitors |
| US7345043B2 (en) | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| US7432808B2 (en) | 2004-12-15 | 2008-10-07 | Intel Corporation | Wireless module enabled component carrier for parts inventory and tracking |
| NZ560267A (en) * | 2005-03-15 | 2010-03-26 | 4Sc Ag | N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| EP1868994B1 (en) * | 2005-04-07 | 2011-05-25 | 4Sc Ag | Sulfonylpyrroles as histone deacetylase inhibitors |
| US8188138B2 (en) * | 2005-09-21 | 2012-05-29 | 4Sc Ag | Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
| US8232297B2 (en) | 2005-09-21 | 2012-07-31 | 4Sc Ag | Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles |
-
2006
- 2006-09-08 US US11/992,015 patent/US8232297B2/en active Active
- 2006-09-08 NZ NZ566074A patent/NZ566074A/en unknown
- 2006-09-08 ES ES06793379T patent/ES2381962T3/es active Active
- 2006-09-08 CN CN2006800347491A patent/CN101268070B/zh active Active
- 2006-09-08 PL PL06793379T patent/PL1928872T3/pl unknown
- 2006-09-08 RS RS20120248A patent/RS52383B/en unknown
- 2006-09-08 KR KR1020087008938A patent/KR101256846B1/ko active IP Right Grant
- 2006-09-08 CA CA2622673A patent/CA2622673C/en active Active
- 2006-09-08 WO PCT/EP2006/066197 patent/WO2007039404A1/en active Application Filing
- 2006-09-08 BR BRPI0617167A patent/BRPI0617167B8/pt active IP Right Grant
- 2006-09-08 JP JP2008530492A patent/JP5305910B2/ja active Active
- 2006-09-08 AT AT06793379T patent/ATE549333T1/de active
- 2006-09-08 EP EP06793379A patent/EP1928872B1/en active Active
- 2006-09-08 EA EA200800700A patent/EA016345B1/ru not_active IP Right Cessation
- 2006-09-08 AU AU2006298882A patent/AU2006298882B2/en active Active
- 2006-09-08 SI SI200631335T patent/SI1928872T1/sl unknown
- 2006-09-08 DK DK06793379.6T patent/DK1928872T3/da active
- 2006-09-08 PT PT06793379T patent/PT1928872E/pt unknown
- 2006-09-21 TW TW095135005A patent/TWI406846B/zh active
- 2006-09-21 AR ARP060104135A patent/AR057824A1/es active IP Right Grant
-
2008
- 2008-02-11 ZA ZA2008/01394A patent/ZA200801394B/en unknown
- 2008-02-26 IL IL189782A patent/IL189782A/en active IP Right Grant
- 2008-04-14 NO NO20081797A patent/NO341744B1/no unknown
-
2009
- 2009-02-19 HK HK09101602.9A patent/HK1124320A1/xx unknown
-
2012
- 2012-05-11 HR HRP20120399TT patent/HRP20120399T1/hr unknown
- 2012-05-21 CY CY20121100465T patent/CY1112780T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1928872T1 (sl) | Novi sulfonilpiroli kot inhibitorji HDAC | |
| ZA200706345B (en) | Amino-pyridines as inhibitors of ß-secretase | |
| HRP20130810T1 (en) | Sulphonylpyrroles as hdac inhibitors | |
| ZA200802585B (en) | Pyridopyrimidinone inhibitors of Pl3Kα | |
| IL190292A0 (en) | PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka | |
| IL197752A0 (en) | Hdac inhibitors | |
| EP1844003A4 (en) | NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR | |
| EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
| ZA200707650B (en) | Azolylacylguanidines as ß-secretase inhibitors | |
| PL2335782T3 (pl) | Zastosowanie kompozycji zawierającej HFCO-1233zd | |
| ZA200805152B (en) | Inhibitors of IAP | |
| IL190753A0 (en) | Compositions of lipoxygenase inhibitors | |
| IL185757A0 (en) | Methods of decreasing calcifcation | |
| EP1957474A4 (en) | SYNTHESIS OF FTFZ INHIBITORS | |
| HK1161122A1 (en) | Use of 24-norudca 24-norudca | |
| GB0624187D0 (en) | HDAC inhibitors | |
| EP1931370A4 (en) | USE OF DES-ASPARTATE-ANGIOTENSIN I | |
| EP1889619A4 (en) | USE OF COMPOUNDS OF THIADIAZOLIDINE AS NEUROGENE AGENTS | |
| ZA200705383B (en) | Benzoyl-tetrahydropyridine as GlyT-1 inhibitors | |
| GB0506443D0 (en) | Novel inhibitors | |
| PT1899354E (pt) | Síntese de desoxibiotinil-hexametilenodiaminadota | |
| AU2005906584A0 (en) | Use of Inhibitors of Prolyl-4-Hydroxylases | |
| AU2006900588A0 (en) | HDAC inhibitor | |
| TWM291236U (en) | Improved structure of bookrack |